IL2 and neoplasm: Finally, the dynamics of the IL-2 compounds in Equation (3) include a source term stimulated by interaction between the tumour cells and the effector cells, degradation and treatment via external input of (typically synthetic) IL-2, which is often used both on its own and in conjunction with other treatment as a form of immunotherapy (Briukhovetska et al.